Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma. [electronic resource]
Producer: 20020911Description: 693-9 p. digitalISSN:- 0735-7907
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Humans
- Liposomes
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Mouth Mucosa -- pathology
- Peripheral Nervous System Diseases -- chemically induced
- Peritoneal Neoplasms -- drug therapy
- Pleural Neoplasms -- drug therapy
- Stomatitis -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.